Exchange: NASDAQ·Updated 07:57 PM EST

TXG Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 05

Estimated EPS

-$0.27

Reported EPS

-$0.15

Surprise

+43.82%

Estimated Rev

$147.96M

Reported Rev

$150.67M

Surprise

+1.83%

• Reported GAAP EPS of -$0.15 up 31.82% YoY • Reported revenue of $150.67M up 1.12% YoY • 10x Genomics expects full year 2026 revenue of $625M to $635M, with 4% to 6% growth over full year 2025 excluding non-recurring license and royalty revenue related to patent litigation settlements.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.22
--
--
N/A
Q3 '26
-$0.27
-$0.15
43.82%
BEAT
Q2 '26
-$0.24
-$0.14
42.41%
BEAT
Q1 '26
-$0.28
-$0.10
63.65%
BEAT
Q4 '25
-$0.20
-$0.13
35.89%
BEAT

Advertisement|Remove ads.